Bioxytran Inc (BIXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2016 | |
| Sales | 32 |
| Cost of Goods | 17 |
| Gross Profit | 15 |
| Operating Expenses | 485 |
| Operating Income | -453 |
| Interest Expense | 2 |
| Pre-tax Income | -455 |
| Net Income Continuous | -455 |
| Net Income | $-455 |
| EPS Basic Total Ops | -0.02 |
| EPS Basic Continuous Ops | -0.02 |
| EPS Diluted Total Ops | -0.02 |
| EPS Diluted Continuous Ops | -0.02 |
| EBITDA(a) | $-442 |